From: Uncovering the roles of microRNAs/lncRNAs in characterising breast cancer subtypes and prognosis
Abbreviation | # RNA | Cohort | Applicable data | Purpose | References |
---|---|---|---|---|---|
CC | – | BC | Multi-omics | Subtyping | [6] |
CNMF | – | BC | Multi-omics | Subtyping | [7] |
iCluster | – | BC | Multi-omics | Subtyping | [8] |
IntClust | — | BC | mRNAs | \(\hbox {Subtyping}^1\) | [9] |
SNF | – | BC | Multi-omics | Subtyping | [10] |
SNF-CC | – | BC | Multi-omics | subtyping | [25] |
WSNF | – | BC | mRNAs, miRNAs | Subtyping | [11] |
CIMLR | – | BC | Multi-omics | Subtyping | [12] |
PINS | – | BC | Multi-omics | Subtyping | [13] |
NEMO | – | BC | Multi-omics | Subtyping | [14] |
intNMF | – | BC | Multi-omics | Subtyping | [67] |
PAM50 | 50 | BC | mRNAs | \(\hbox {Subtyping}^1\) | [15] |
rorS | 50 | BC | mRNAs | Prognosis | [15] |
GENE70 | 70 | ER+ | mRNAs | Prognosis | [16] |
OncotypeDX | 21 | ER+ | mRNAs | Prognosis | [17] |
GGI | 97 | ER+ | mRNAs | Prognosis | [18] |
Tamr13 | 181 | ER+ | mRNAs | Prognosis | [19] |
AURKA | 1 | BC | mRNA | Prognosis | [20] |
ESR1 | 1 | BC | mRNA | Prognosis | [20] |
ERBB2 | 1 | BC | mRNA | Prognosis | [20] |
GENIUS | 314 | BC | mRNAs | Prognosis | [21] |
PIK3CAGS | 278 | ER+ | mRNAs | Prognosis | [22] |
EndoPredict | 11 | ER+ | mRNAs | Prognosis | [23] |
Ensemble | 238 | BC | mRNAs | Prognosis | Additional file 1 |
miR-21 | 1 | BC | miRNA | Prognosis | |
miR-155 | 1 | BC | miRNA | Prognosis | [72] |
miR-210 | 1 | BC | miRNA | Prognosis | |
RNAmodel | 37 | BC | mRNAs, miRNAs | Prognosis | [38] |
miRNA10 | 10 | BC | miRNAs | Prognosis | [43] |
HOTAIR | 1 | BC | lncRNA | Prognosis | [75] |
MALAT1 | 1 | BC | lncRNA | Prognosis | [76] |
DSCAM-AS1 | 1 | BC | lncRNA | Prognosis | [77] |
lncRNA12 | 12 | BC | lncRNAs | Prognosis | [39] |
LncRNA6 | 6 | ER+ | lncRNAs | Prognosis | [40] |
LncRNA5 | 5 | BC | lncRNAs | Prognosis | [41] |